By Molika Ashford

A European consortium aims to generate more than 100 reference epigenomes of hematopoietic cells in an effort to accelerate clinical research, biomarker discovery, technology, and drug development for epigenetic targets.

The consortium, called the Blueprint of Haematopoietic Epigenomes project, or Blueprint for short, has secured €30 million ($40.6 million) from the European Union's Seventh Framework Program and includes 41 institutes, universities, and companies.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.